Herald Investment Management Ltd Boosts Holdings in Mesa Laboratories, Inc. $MLAB

Herald Investment Management Ltd grew its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 300.0% in the third quarter, Holdings Channel reports. The institutional investor owned 50,000 shares of the medical instruments supplier’s stock after buying an additional 37,500 shares during the period. Herald Investment Management Ltd’s holdings in Mesa Laboratories were worth $3,340,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Farther Finance Advisors LLC raised its holdings in Mesa Laboratories by 17,733.3% during the third quarter. Farther Finance Advisors LLC now owns 535 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 532 shares in the last quarter. CWM LLC increased its position in Mesa Laboratories by 48.9% during the 3rd quarter. CWM LLC now owns 597 shares of the medical instruments supplier’s stock worth $40,000 after purchasing an additional 196 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Mesa Laboratories by 115.3% during the 2nd quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier’s stock worth $74,000 after buying an additional 421 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of Mesa Laboratories by 432.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock valued at $79,000 after buying an additional 684 shares during the period. Finally, MQS Management LLC purchased a new stake in shares of Mesa Laboratories in the second quarter valued at approximately $207,000. Institutional investors and hedge funds own 90.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Wells Fargo & Company boosted their target price on shares of Mesa Laboratories from $83.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Weiss Ratings reissued a “sell (d)” rating on shares of Mesa Laboratories in a report on Thursday, January 22nd. Zacks Research upgraded shares of Mesa Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, January 9th. Finally, Wall Street Zen upgraded shares of Mesa Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 7th. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Mesa Laboratories currently has a consensus rating of “Reduce” and a consensus price target of $94.00.

Mesa Laboratories Price Performance

Shares of NASDAQ:MLAB opened at $90.59 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.45 and a current ratio of 1.94. The business’s fifty day moving average price is $83.45 and its two-hundred day moving average price is $75.45. The stock has a market cap of $500.06 million, a PE ratio of 141.55 and a beta of 0.89. Mesa Laboratories, Inc. has a one year low of $55.45 and a one year high of $152.03.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Tuesday, February 3rd. The medical instruments supplier reported $3.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.41 by $0.66. The business had revenue of $65.13 million for the quarter, compared to the consensus estimate of $63.23 million. Mesa Laboratories had a return on equity of 22.02% and a net margin of 1.51%. On average, analysts forecast that Mesa Laboratories, Inc. will post 8 EPS for the current fiscal year.

Mesa Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Saturday, February 28th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, February 27th. Mesa Laboratories’s dividend payout ratio (DPR) is currently 100.00%.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.